Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ting Xiong, Xinyue Bai, Xingyi Wei, Lezheng Wang, Fei Li, Hui Shi & Yue Shi. (2023) Exercise Rehabilitation and Chronic Respiratory Diseases: Effects, Mechanisms, and Therapeutic Benefits. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1251-1266.
Read now
Read now
Jiexing Liu, Zhuonan Ran, Fen Wang, Caiyan Xin, Bin Xiong & Zhangyong Song. (2021) Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease. Critical Reviews in Microbiology 47:1, pages 1-12.
Read now
Read now
Karolina Sidletskaya, Tatyana Vitkina & Yulia Denisenko. (2020) The Role of Toll-Like Receptors 2 and 4 in the Pathogenesis of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1481-1493.
Read now
Read now
Hsueh-Yi Lu & Kuang-Ming Liao. (2018) Risk of empyema in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 317-324.
Read now
Read now
Fadime Mutlu Icduygu, Mujgan Ozdemir Erdogan, Sevinc Sarinc Ulasli, Handan Gonenli Yildiz, Zeynep Sonmez Celik, Mehmet Unlu & Mustafa Solak. (2017) Is There an Association Between NOD2 Gene Polymorphisms and Chronic Obstructive Pulmonary Disease Progression?. International Journal of Human Genetics 17:2, pages 86-96.
Read now
Read now
Articles from other publishers (10)
Naser Alizadeh, Ghazal Naderi, Mohammad saeed Kahrizi, Tannaz Haghgouei, Ahmad Mobed & Mehran Ebrahimi shah-abadi. (2022) Microbiota-Pain Association; Recent Discoveries and Research Progress. Current Microbiology 80:1.
Crossref
Crossref
I. A. Yatskov, V. A. Beloglazov & E. I. Ryapova. (2022) Lipopolysaccharide and ARDS caused by new coronavirus infection: hypotheses and facts. Medical Immunology (Russia) 24:1, pages 7-18.
Crossref
Crossref
Vasilii D. FedotovA.V. ZhestkovArtem V. LyaminM.I. ZaslavskayaI.S. DobrotinaA.A. Tulichev. (2022) Microbiota in the pathogenesis of COPD and its impact on the course of the disease. Clinical Microbiology and Antimicrobial Chemotherapy 24:3, pages 202-212.
Crossref
Crossref
Karolina A. Sidletskaya, Tatyana I. Vitkina, Yulia K. Denisenko & Elena E. Mineeva. (2021) Role of Toll-Like Receptor 2 in Regulation of T-Helper Immune Response in Chronic Obstructive Pulmonary Disease. Canadian Respiratory Journal 2021, pages 1-8.
Crossref
Crossref
Yu. K. Denisenko, T. P. Novgorodtseva, V. V. Knyshova & M. V. Antonyuk. (2021) Polyunsaturated fatty acid status of leukocyte membranes in COPD patients. Medical Immunology (Russia) 23:1, pages 157-162.
Crossref
Crossref
Alexander G Mathioudakis, Sadia Janjua, Rebecca Normansell & Jørgen Vestbo. (2018) Biomarkers to guide antibiotic therapy for COPD exacerbations. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Juliana Ruiz Fernandes, Cibele Cristine Berto Marques da Silva, Aline Grandi da Silva, Regina Maria de Carvalho Pinto, Alberto José da Silva Duarte, Celso Ricardo Carvalho & Gil Benard. (2018) Effect of an Exercise Program on Lymphocyte Proliferative Responses of COPD Patients. Lung 196:3, pages 271-276.
Crossref
Crossref
Alexander G. Mathioudakis, Victoria Chatzimavridou-Grigoriadou, Alexandru Corlateanu & Jørgen Vestbo. (2017) Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis. European Respiratory Review 26:143, pages 160073.
Crossref
Crossref
NF WatsonD Buchwald, JJ DelrowWA AltemeierMV VitielloAI PackM Bamshad, C Noonan & SA Gharib. (2017) Transcriptional Signatures of Sleep Duration Discordance in Monozygotic Twins. Sleep 40:1.
Crossref
Crossref
Huong Q. Nguyen, Jerald R. Herting, Kenneth C. Pike, Sina A. Gharib, Gustavo Matute-Bello, Soo Borson, Ruth Kohen, Sandra G. Adams & Vincent S. Fan. (2016) Symptom profiles and inflammatory markers in moderate to severe COPD. BMC Pulmonary Medicine 16:1.
Crossref
Crossref